Can Epigenetic and Gastric Microbiome Markers Predict the Risk of Helicobacter pylori -Negative Gastric Cancer?

참고문헌 (9)

1. Ford AC, "Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals : systematic review and meta-analysis of randomised controlled trials", BMJ, 348, pp.g3174~ (2014)
2. Kajihara Y, "Short-term trends in gastric cancer incidence after insurance coverage expansion for Helicobacter pylori eradication in Japan", Eur J Intern Med (2024)[DOI]
3. Ushijima T, "Epigenetic field for cancerization", J Biochem Mol Biol, 40, pp.142~150 (2007)
4. Shin CM, "Aberrant DNA methylation maker for predicting metachronous recurrence after endoscopic resection of gastric neoplasms", Cancer Res Treat, 54, pp.1157~1166 (2022)
5. Asada K, "Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study", Gut, 64, pp.388~396 (2015)
6. Barra WF, "Gastric cancer microbiome", Pathobiology, 88, pp.156~169 (2021)
7. Shin CM, "Alternations of gastric microbiota with mucosal atrophy and intestinal metaplasia", Korean J Helicobacter Up Gastrointest Res, 20, pp.187~195 (2020)
8. Niikura R, "Non-Helicobacter pylori gastric microbiome modulates prooncogenic responses and is associated with gastric cancer risk", Gastro Hep Advances, 2, pp.684~700 (2023)
9. Kim MJ, "Combined DNA methylation and gastric microbiome marker predicts Helicobacter pylori-negative gastric cancer", Gut Liver, 18, pp.611~620 (2024)

관련 논문AI추천